Four takeaways:
1. Preliminary and unaudited revenue for the fourth quarter is in the range of $27.7 million to $28.1 million.
2. Sinuva had a quarterly revenue of about $2.5 million.
3. Vensure initiated U.S. sales with revenue of approximately $300,000.
4. Cash, cash equivalents and restricted cash were expected to be approximately $105 million as of Dec. 31, 2020.
Intersect ENT’s full fourth-quarter report is expected March 9.
More articles on surgery centers:
California hospital temporarily converts ASC into ICU
Surgery Partners reports $1.86B in 2020 revenue: 11 things to know
Are surgical robots worth it for ASCs? 3 administrators weigh in
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
